Agilent

1D
1W
1M
3M
YTD
1Y
5Y
ALL

Why Robinhood?

Robinhood gives you the tools you need to put your money in motion. You can buy or sell Agilent and other ETFs, options, and stocks.

About A

Agilent Technologies, Inc. engages in the provision of application focused solutions for life sciences, diagnostics, and applied chemical markets. It operates through the following segments: Life Sciences and Diagnostics Markets, Applied Markets, and Agilent CrossLab. 

CEO
Padraig Mcdonnell
CEOPadraig Mcdonnell
Employees
18,100
Employees18,100
Headquarters
Santa Clara, California
HeadquartersSanta Clara, California
Founded
1999
Founded1999
Employees
18,100
Employees18,100

A Key Statistics

Market cap
31.71B
Market cap31.71B
Price-Earnings ratio
24.86
Price-Earnings ratio24.86
Dividend yield
0.89%
Dividend yield0.89%
Average volume
2.27M
Average volume2.27M
High today
$112.39
High today$112.39
Low today
$110.34
Low today$110.34
Open price
$111.60
Open price$111.60
Volume
706.03K
Volume706.03K
52 Week high
$160.27
52 Week high$160.27
52 Week low
$96.43
52 Week low$96.43

Stock Snapshot

The current Agilent(A) stock price is $112.20, with a market capitalization of 31.71B. The stock trades at a price-to-earnings (P/E) ratio of 24.86 and offers a dividend yield of 88.6%.

As of 2026-03-18, Agilent(A) stock has fluctuated between $110.34 and $112.39. The current price stands at $112.20, placing the stock +1.7% above today's low and -0.2% off the high.

Agilent(A) shares are trading with a volume of 706.03K, against a daily average of 2.27M.

In the last year, Agilent(A) shares hit a 52-week high of $160.27 and a 52-week low of $96.43.

In the last year, Agilent(A) shares hit a 52-week high of $160.27 and a 52-week low of $96.43.

A News

TipRanks 2d
Rising helium prices could create headwind for Bruker, says Jefferies

Jefferies analyst Tycho Peterson notes headlines surfaced last week around helium price shocks amid the escalating conflict in the Middle East, where 20% of the...

Simply Wall St 6d
Agilent Expands CDMO Role With Advanced Therapeutics As Shares Lag Targets

Agilent Technologies (NYSE:A) has launched Agilent Advanced Therapeutics, a unified CDMO platform. The platform integrates BIOVECTRA in Canada and Nucleic Acid...

Agilent Expands CDMO Role With Advanced Therapeutics As Shares Lag Targets

Analyst ratings

78%

of 23 ratings
Buy
78.3%
Hold
21.7%
Sell
0%

People also own

Based on the portfolios of people who own A. This list is generated using Robinhood data, and it’s not a recommendation.

Similar Marketcap

This list is generated by looking at the six larger and six smaller companies by market cap in relation to this company.

Popular Stocks

This list is generated by looking at the top 100 stocks and ETFs most commonly held by Robinhood customers and showing a random subset

Newly Listed

This list is generated by showing companies that recently went public.

All investments involve risks, including the loss of principal. Securities trading offered through Robinhood Financial LLC, Member SIPC and a registered broker-dealer. Options are risky and aren’t suitable for all investors. To learn more about risks, read the Options Disclosure Document.